Stay updated with breaking news from David Schull. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CORAL GABLES, Fla., Nov. 16, 2023 -- Catalyst Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for...
SARASOTA, Fla. and AVENTURA, Fla., Nov. 10, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO ) ("INVO"), a healthcare services company focused on expanding access to advanced fertility treatment worldwide,
SARASOTA, Fla. and AVENTURA, Fla., Nov. 10, 2023 /PRNewswire/ -- INVO Bioscience, Inc. , a healthcare services company focused on expanding access to advanced fertility treatment worldwide, and...
CORAL GABLES, Fla., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (NASDAQ:CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,
Standardizes and improves product reimbursement process New HCPCS Level II code J1105 to be effective January 1, 2024 NEW HAVEN, Conn., Oct. 30, 2023 -- BioXcel Therapeutics, Inc. , a...